Evidence map›Paper›PMID 41492633›Full record

ArticleCureus2025

Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker of Disease Severity in Community-Acquired Pneumonia Among Hospitalized Patients From Northeast India.

Abhisek Ghosh, Aritra Banerjee, Pranjeeta Deka, Deepak K Pandey, Dibya J Sharma, Akash Batta

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abhisek GhoshGeneral Medicine, Silchar Medical College and Hospital, Silchar, IND.
Aritra BanerjeeMedicine, Silchar Medical College and Hospital, Silchar, IND.
Pranjeeta DekaMedicine, Silchar Medical College and Hospital, Silchar, IND.
Deepak K PandeyMedicine, Silchar Medical College and Hospital, Silchar, IND.
Dibya J SharmaInternal Medicine/Gastroenterology, Silchar Medical College and Hospital, Silchar, IND.
Akash BattaCardiology, Dayanand Medical College and Hospital, Ludhiana , IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of the neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker for community-acquired pneumonia (CAP) has not been extensively studied in India. Therefore, we conducted this study to assess the role of the NLR in determining prognosis and severity among hospitalized CAP patients from Northeast India. MATERIALS AND

methodsThis prospective observational study was conducted from October 2023 to November 2024 in a tertiary care hospital in southern Assam, Northeast India. A total of 162 adult patients with CAP were recruited for the study via consecutive sampling. Statistical analysis included descriptive statistics, chi-square tests, correlation analysis, and logistic regression to evaluate associations between NLR, severity scores (CURB-65), and patient outcomes.

resultsA strong positive correlation (r = 0.72) was noted between the NLR and CURB-65 score. A level of NLR ≥ 9.5 anticipated the need for intensive care unit (ICU) admission (40.74%, n=66 out of 162), while NLR ≥ 16 was associated with a higher death rate (80%, n=16; out of 20 deaths) compared to NLR <16 (20%, n=4). Most patients (55%) were middle-aged men. Right middle zone pneumonia (22.8%) was the most frequent radiological finding, while 85.18% patients had sterile sputum culture. Both Klebsiella pneumoniae (6.2%) and Streptococcus pneumoniae (6.2%) were the most typical organisms noted in the culture specimen.  Conclusion: An elevated NLR is a strong predictor of disease severity, ICU requirement and mortality amongst Indian CAP patients.

Indexed as

biomarkercommunity-acquired pneumonia (cap)curb-65 scoremedical icumortalityneutrophil-to-lymphocyte ratio (nlr)prognosisseverity

Identifiers

PMID41492633
PMCPMC12765456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.